New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
133.09+0.93 (+0.70%)
At close: 04:02PM EST
133.00 -0.09 (-0.07%)
After hours: 07:57PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 221.82B
Enterprise value 290.29B
Trailing P/E 30.31
Forward P/E 8.95
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.04
Price/book (mrq)16.37
Enterprise value/revenue 5.26
Enterprise value/EBITDA 15.87

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 328.57%
S&P500 52-week change 317.58%
52-week high 3138.15
52-week low 3101.81
50-day moving average 3127.16
200-day moving average 3116.78

Share statistics

Avg vol (3-month) 36.73M
Avg vol (10-day) 38.89M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.75B
% held by insiders 10.12%
% held by institutions 168.26%
Shares short (30 Dec 2021) 416.61M
Short ratio (30 Dec 2021) 42.42
Short % of float (30 Dec 2021) 40.94%
Short % of shares outstanding (30 Dec 2021) 40.94%
Shares short (prior month 29 Nov 2021) 414.12M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 44.24%
Trailing annual dividend rate 35.20
Trailing annual dividend yield 33.93%
5-year average dividend yield 44.28
Payout ratio 4122.71%
Dividend date 314 Feb 2022
Ex-dividend date 412 Jan 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 13.66%
Operating margin (ttm)36.70%

Management effectiveness

Return on assets (ttm)8.48%
Return on equity (ttm)52.25%

Income statement

Revenue (ttm)55.17B
Revenue per share (ttm)31.19
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)31.75B
Net income avi to common (ttm)7.46B
Diluted EPS (ttm)4.20
Quarterly earnings growth (yoy)37.70%

Balance sheet

Total cash (mrq)12.25B
Total cash per share (mrq)6.93
Total debt (mrq)80.74B
Total debt/equity (mrq)594.66
Current ratio (mrq)1.01
Book value per share (mrq)7.66

Cash flow statement

Operating cash flow (ttm)22.56B
Levered free cash flow (ttm)20.34B